Pneumococcal Infections Clinical Trials

131 clinical trials for Pneumococcal Infections across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• National, Non Interventional Study of Invasive Pneumococcal Disease in Children and Newborns — RECRUITING
• Immunogenicity and Safety PCV-20 of the Vaccine Administered During an Acute Febrile Illness in Adults — RECRUITING · PHASE4
• In-depth Analysis of the Immune Responses in the Upper Respiratory Tract in Older Adults Infected or Colonized With Streptococcus Pneumoniae (Spn) — RECRUITING
• A Phase 3 Study to Evaluate the Immunogenicity and Safety of Minhai's PCV13-DT/TT Vaccine As Compared to Pfizer's PCV13 Vaccine — RECRUITING · PHASE3
• Safety and Immunogenicity Following Meningococcal and Pneumococcal Immunization Among Adult People Living With HIV — RECRUITING · PHASE4
• A trial to evaluate the safety and immune response of a pneumococcal conjugate vaccine in adults 18 years of age and older, who have not previously received a pneumococcal vaccine — COMPLETED · PHASE3
• A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infants Aged 2 Months (Minimum 6 Weeks) — ACTIVE_NOT_RECRUITING · PHASE3
• A Clinical Trial of the 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/Tetanus Toxoid) — NOT_YET_RECRUITING
• Surveillance of Invasive Pneumococcal Infections in Adults (Excluding Meningitis) — COMPLETED
• RANDOMIZED CONTROLLED TRIAL OF TEXT MESSAGE TO INCREASE PNEUMOCOCCAL VACCINATION IN ADULTS IN CHILE. — NOT_YET_RECRUITING · NA
• Systematic Search for Primary Immunodeficiency in Adults With Infections — COMPLETED · NA
• Evaluation of Prime-boost Anti-pneumococcal Vaccination in Patients With Diffuse Large B Cell Lymphoma Treated With Rituximab — COMPLETED · PHASE3
• Safety and Immunogenicity Study of a 13-valent Pneumococcal Polysaccharide Conjugate Vaccine — COMPLETED · PHASE1
• A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy Infants — COMPLETED · PHASE2
• Study of the Safety and Immunogenicity of Catch-up Vaccination With a 21-valent Pneumococcal Conjugate Vaccine (PCV21) in Healthy Infants, Toddlers, Children, and Adolescents — ACTIVE_NOT_RECRUITING · PHASE3
• Evaluating the Effectiveness of a Pneumococcal Immunisation Campaign in a Camp for Internally Displaced People — ACTIVE_NOT_RECRUITING · PHASE4
• Serotype Distribution in Hospitalized Adult With Pneumococcal Community Acquired Pneumonia in France — COMPLETED
• Safety, Tolerability, and Immunogenicity of V114 in Healthy Japanese Infants (V114-028) — COMPLETED · PHASE1
• Extension Safety and Immunogenicity Study of GPNV-001 — COMPLETED · PHASE1
• A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Infants and Young Children — COMPLETED · PHASE3
• Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Native Elders — COMPLETED · PHASE1
• The Effect of AUDIT and Feedback on Pneumococcal Vaccination Coverage — NOT_YET_RECRUITING · NA
• Safety, Tolerability and Immunogenicity of an Inactivated Whole-cell Pneumococcal Vaccine Gamma-PN3. — COMPLETED · PHASE1
• Immunization To Prevent Acute COPD Exacerbations — TERMINATED
• A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU) — COMPLETED · PHASE3
• Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i) — COMPLETED · PHASE3
• Sequential Versus Simultaneous Pneumococcal Vaccination in Elderly: Immunological Memory and Antibody Levels — COMPLETED · PHASE4
• Immunogenicity and Safety of 23-valent Pneumococcal Polysaccharide Vaccine — COMPLETED · PHASE4
• Lot-to-lot Consistency of 23-valent Pneumococcal Polysaccharide Vaccine — COMPLETED · PHASE4
• Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-025) — COMPLETED · PHASE3
• A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Allogeneic Hematopoietic Stem Cell Transplant Recipients (V114-022/PNEU-STEM) — COMPLETED · PHASE3
• Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029) — COMPLETED · PHASE3
• Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Healthy Japanese Infants (V114-033) — COMPLETED · PHASE3
• A Study to Evaluate the Safety and Tolerability of V114 and Prevnar 13™ in Healthy Infants (V114-031/PNEU-LINK) — COMPLETED · PHASE3
• Safety and Immunogenicity of V114 in Children Infected With Human Immunodeficiency Virus (HIV) (V114-030/PNEU-WAY PED) — COMPLETED · PHASE3
• Safety, Tolerability, and Immunogenicity of a 3-dose Regimen of V114 in Healthy Infants (PNEU-PED-EU-2/V114-026) — COMPLETED · PHASE3
• Concomitant Administration of the Novavax Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Adults Aged ≥60 Years — OTHER · PHASE4
• A Study to Evaluate the Interchangeability of V114 and Prevnar 13™ in Healthy Infants (V114-027/PNEU-DIRECTION) — COMPLETED · PHASE3
• Safety and Immunogenicity of Catch-up Vaccination Regimens of V114 (V114-024) — COMPLETED · PHASE3
• Phase I Clinical Trial of a Candidate PCV13 in Healthy People — OTHER · PHASE1
• Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above — COMPLETED · PHASE1
• A Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine — COMPLETED · PHASE4
• A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults Infected With Human Immunodeficiency Virus (HIV) (V114-018) — COMPLETED · PHASE3
• Impact of Pharmacist-led Educational Intervention on Pneumococcal Vaccination Rates in Cancer Patients — COMPLETED · NA
• Pneumococcal Vaccination in Patients With Chronic Lymphocytic Leukaemia — OTHER
• Study to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine Given With Prevnar 13 in Healthy Infants — TERMINATED · PHASE2
• Study Comparing a 13-valent Pneumococcal Conjugate Vaccine With 23-valent Pneumococcal Polysaccharide Vaccine in Adults — COMPLETED · PHASE3
• Evaluation of the Safety and Immunogenicity of Sequential Administration of Prevnar 13™ and Pneumovax™ 23 in Healthy Participants 50 Years of Age and Older (V110-029) — COMPLETED · PHASE3
• A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Healthy Adults 50 Years of Age or Older (V114-016/PNEU-PATH) — COMPLETED · PHASE3
• Evaluating the Safety and Immune Response to Two Pneumococcal Vaccines in HIV-Infected Pregnant Women — WITHDRAWN · PHASE2

Refine this search